(Washington, DC – May 3, 2016) –  Galileo Analytics Co-Founder Anna McCollister-Slipp will join senior HHS officials, entrepreneurs and privacy experts on a panel next week at Privacy and Security 2.0: From Challenge to Enabler, a special HHS symposium following the 2016 Health Datapalooza.

McCollister-Slipp’s panel, which will be moderated by HHS Chief Technology Officer Susannah Fox, will focus on the need for interoperability in health care information technology systems used by hospitals, local clinics, research institutions and medical devices.

More information about the panel on interoperability is below. For those who are unable to attend in person, HHS and Health Datapalooza will offer live streaming of this year’s Health Datapalooza events:

Focus on Interoperability

May 11, 2016, 1 pm to 2:15 pm EDT

Location: Great Hall, Hubert H. Humphrey Building; U.S. Department of Health and Human Services

This session will focus on the critical role of interoperability – both among health care providers and health plans, for appropriate reasons (treatment, payment, care coordination), and between providers and plans and patients.

Speakers:

  • Susannah Fox, HHS (Moderator)
  • Aja Brooks, Office of the National Coordinator
  • Christina Heide, Office for Civil Rights, HHS
  • Anna McCollister-Slipp, Galileo Analytics
  • Drew Schiller, Validic

For more information about the symposium and Health Datapalooza see below:

Privacy and Security 2.0: From Challenge to Enabler

Health Datapalooza 2016

###

Admin

About Admin

Anna McCollister-Slipp is co-founder of Galileo Analytics, a Visual Data Exploration and advanced data analytics company focused on democratizing access to and understanding of complex health data. In addition, she is the Chief Advocate for Participatory Research at the Scripps Translational Science Institute, where she is charged with bringing the expertise of patients, caregivers and community physicians into the design of health research. Anna’s passion for innovation in health data research is rooted in her personal experiences living with type 1 diabetes. As an entrepreneur and advocate, she speaks frequently about the promise of digital health, the imperative for patient data access and the need for improved outcomes measures for chronic disease. Anna serves on a number of government and private committees and boards aimed at promoting innovative ways to better understand, manage and treat complex health conditions, such as diabetes.

%d bloggers like this: